Cargando…
Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease worldwide. However, there is no available therapy reversing the neurodegenerative process of PD. Based on the loss of dopamine or dopaminergic dysfunction in PD patients, most of the current therapies focus on s...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471472/ https://www.ncbi.nlm.nih.gov/pubmed/32112042 http://dx.doi.org/10.1038/s41401-020-0365-y |